El problema del huevo y la gallina en la lucha contra otra pandemia de gripe
By Arthur Allen
May 31, 2024
KFF Health News Original
La propagación de un nuevo virus entre múltiples especies en un área geográfica amplia eleva la amenaza de que más mutaciones puedan producir un virus que se propague de humano a humano a través de la transmisión aérea.
Third US Case of Bird Flu Confirmed; First With Respiratory Symptoms
May 30, 2024
Morning Briefing
Michigan health officials and the CDC confirmed Thursday that a second person in the state has been infected with bird flu. It’s the third human infection associated with the U.S. outbreak in cattle. This dairy farm worker is the first to present with respiratory symptoms — a cough, though no fever — as well as “eye discomfort” present in the other two cases. All three people were exposed to infected cattle and there’s no evidence the virus is spreading from person to person.
KFF Health News' 'What the Health?': Waiting for SCOTUS
May 30, 2024
Podcast
June is when the Supreme Court typically issues rulings in the major cases it hears during that year’s term. This year, those interested in health policy are awaiting decisions in two abortion-related cases and one that could reshuffle the way health policies (and all other federal policies) are made. In this special episode, KFF’s Laurie Sobel, associate director for women’s health policy, joins Julie Rovner for a review of the cases and a preview of how the court might rule.
Wyden Demands Penalties for Obamacare Enrollment Fraud
By Julie Rovner
May 30, 2024
KFF Health News Original
Lawmakers and state officials are turning up the heat on federal regulators to stop unscrupulous, commission-hungry insurance agents from enrolling thousands of people in Affordable Care Act plans, or switching their coverage, without their knowledge. Customers often don’t discover the changes until they’re denied medical coverage or get stuck with a bill for ACA tax […]
Night Owls Take Note: Study Finds Late Bedtimes May Harm Mental Health
May 30, 2024
Morning Briefing
Research shows that going to sleep later may have a negative impact on mental health, regardless of whether the person is a night owl or early bird. Separately, another study finds that placebo drugs can improve mental health symptoms.
Fla. Gov. DeSantis Signs Into Law ‘Rural Emergency Hospitals’ Designation
May 30, 2024
Morning Briefing
The legislation, which passed unanimously, goes into effect July 1. Other health news from around the country is on sex designation on Montana birth certificates, naloxone in Texas, homelessness in California’s San Mateo County, and more.
Research Roundup: Dengue Virus; Alzheimer’s; Bird Flu Vaccines; Covid
May 30, 2024
Morning Briefing
Each week, KFF Health News compiles a selection of health policy studies and briefs.
Viewpoints: Is There Really A Maternal-Mortality Crisis?; EMTALA Threatens Reproductive Health Care
May 30, 2024
Morning Briefing
Editorial writers examine issues in reproductive health care, mpox, syphilis, and more.
Morning Briefing for Thursday, May 30, 2024
May 30, 2024
Morning Briefing
ACA subsidies, drug discount program, Medicaid “unwinding,” vaping, reproductive health, cyber security, weight loss drugs, and more stories.
Girls’ First Periods Are Coming Earlier And Are Less Regular, Study Shows
May 30, 2024
Morning Briefing
Early menstruation – with early exposure to estrogen – is related to an increased risk of myriad health issues, including death. Moreover, the premature periods are more pronounced among Black and low-income girls.
FDA: Nicotine Alternatives In Vapes May Be More Addictive Than Nicotine
May 30, 2024
Morning Briefing
Reuters points out that the synthetic, nicotine-like substances are not subject to U.S. tobacco and vaping regulations. In related news, a New York judge’s ruling offers a break to Pfizer in its legal battle over the smoking-cessation drug Chantix.
‘Botnet’ That Stole Nearly $6 Billion In US Covid Relief Funds Is Shut Down
May 30, 2024
Morning Briefing
The Department of Justice has charged a Chinese national with operating the “world’s largest botnet” that stole $5.9 billion in covid relief funds and is responsible for other crimes. With the FBI, the agency has also shut down the malware network.
Ascension’s Health Records Are Back Online In One Area After Cyberattack
May 30, 2024
Morning Briefing
The hospital system is still working to restore access in other areas and on its IT systems. Other news is on DocGo, liver transplant policy, Obamacare subsidies, and more.
Weight Loss Drug Shortages Drive Telehealth Company To Offer Tracker
May 30, 2024
Morning Briefing
The popularity of diabetes drugs like Ozempic and Mounjaro has led to shortages. Patients with prescriptions can now use Ro’s new online tool to find supplies. Other news on the medications reports on the cost to the U.S. health care system and on users’ firsthand experiences.
First Edition: May 30, 2024
May 30, 2024
Morning Briefing
Today’s early morning highlights from the major news organizations.
Presidential Election Could Decide Fate of Extra Obamacare Subsidies
By Andy Miller
May 30, 2024
KFF Health News Original
Most states that saw enrollment in the Obamacare marketplace double from 2020 to 2024 are in the South. But the enhanced federal subsidies that attracted people with $0 premiums and low out-of-pocket costs will expire next year.
An Obscure Drug Discount Program Stifles Use of Federal Lifeline by Rural Hospitals
By Sarah Jane Tribble
May 30, 2024
KFF Health News Original
A disconnect between two federal programs meant to help keep hospitals afloat discourages struggling rural facilities from accepting the aid.
Safety-Net Health Clinics Cut Services and Staff Amid Medicaid ‘Unwinding’
By Katheryn Houghton
May 30, 2024
KFF Health News Original
One of Montana’s largest safety-net health centers announced it will lay off nearly 10% of its workforce because of revenue losses it attributes to vast Medicaid disenrollments. Such cuts are happening elsewhere too.
J&J, Merck Break Out The Big Bucks In Separate Billon-Dollar Deals
May 29, 2024
Morning Briefing
Johnson & Johnson is paying $1.25 billion to acquire the rights to an experimental skin disorder treatment, while Merck is reportedly nearing a $1.3 billion deal to buy Eyebiotech.
Complex US Health System To Blame For High Cost Of Ozempic, Novo Says
May 29, 2024
Morning Briefing
Read recent pharmaceutical developments in KFF Health News’ Prescription Drug Watch roundup.
